Matinas biopharma to present at the 12th annual bionj biopartnering conference

Bedminster, n.j., may 03, 2022 (globe newswire) -- matinas biopharma (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announced today that jerry jabbour, chief executive officer, has been invited to present at the 12th annual bionj biopartnering conference, co-sponsored by j.p. morgan and j&j innovation, being held virtually may 9-13, 2022.
MTNB Ratings Summary
MTNB Quant Ranking